Global Drug Eluting Coronary Stent Production, Demand and Key Producers, 2022-2028
This report studies the global Drug Eluting Coronary Stent production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Eluting Coronary Stent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Eluting Coronary Stent that contribute to its increasing demand across many markets.
The global Drug Eluting Coronary Stent market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Drug Eluting Coronary Stent total production and demand, 2017-2028, (K Units)
Global Drug Eluting Coronary Stent total production value, 2017-2028, (USD Million)
Global Drug Eluting Coronary Stent production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug Eluting Coronary Stent consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Drug Eluting Coronary Stent domestic production, consumption, key domestic manufacturers and share
Global Drug Eluting Coronary Stent production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Drug Eluting Coronary Stent production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug Eluting Coronary Stent production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Drug Eluting Coronary Stent market based on the following parameters – headquarters, production locations, products portfolio, Drug Eluting Coronary Stent revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Eluting Coronary Stent market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Drug Eluting Coronary Stent Market, By Region:
1. How big is the global Drug Eluting Coronary Stent market?
2. What is the demand of the global Drug Eluting Coronary Stent market?
3. What is the year over year growth of the global Drug Eluting Coronary Stent market?
4. What is the production and production value of the global Drug Eluting Coronary Stent market?
5. Who are the key producers in the global Drug Eluting Coronary Stent market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Drug Eluting Coronary Stent, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Eluting Coronary Stent that contribute to its increasing demand across many markets.
The global Drug Eluting Coronary Stent market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Drug Eluting Coronary Stent total production and demand, 2017-2028, (K Units)
Global Drug Eluting Coronary Stent total production value, 2017-2028, (USD Million)
Global Drug Eluting Coronary Stent production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug Eluting Coronary Stent consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Drug Eluting Coronary Stent domestic production, consumption, key domestic manufacturers and share
Global Drug Eluting Coronary Stent production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Drug Eluting Coronary Stent production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drug Eluting Coronary Stent production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Drug Eluting Coronary Stent market based on the following parameters – headquarters, production locations, products portfolio, Drug Eluting Coronary Stent revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Eluting Coronary Stent market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Drug Eluting Coronary Stent Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Sirolimus
- Everolimus
- Others
- Angina Pectoris
- Myocardial Infarction
- Boston Scientific
- Medtronic
- Abbott
- Sahajanand Laser Technology Limited (SLTL Group)
- Meril Life Sciences
- Concept Medical
- BIOTRONIK
- Relisys
- Lepu Medical Technology(Beijing)
- Micell Technologies
- Terumo Corporation
- Biosensors International
1. How big is the global Drug Eluting Coronary Stent market?
2. What is the demand of the global Drug Eluting Coronary Stent market?
3. What is the year over year growth of the global Drug Eluting Coronary Stent market?
4. What is the production and production value of the global Drug Eluting Coronary Stent market?
5. Who are the key producers in the global Drug Eluting Coronary Stent market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drug Eluting Coronary Stent Introduction
1.2 World Drug Eluting Coronary Stent Supply & Forecast
1.2.1 World Drug Eluting Coronary Stent Production Value (2017 & 2021 & 2028)
1.2.2 World Drug Eluting Coronary Stent Production (2017-2028)
1.2.3 World Drug Eluting Coronary Stent Pricing Trends (2017-2028)
1.3 World Drug Eluting Coronary Stent Production by Region
1.3.1 World Drug Eluting Coronary Stent Production Value by Region (2017-2028)
1.3.2 World Drug Eluting Coronary Stent Production by Region (2017-2028)
1.3.3 World Drug Eluting Coronary Stent Average Price by Region (2017-2028)
1.3.4 North America Drug Eluting Coronary Stent Production (2017-2028)
1.3.5 Europe Drug Eluting Coronary Stent Production (2017-2028)
1.3.6 China Drug Eluting Coronary Stent Production (2017-2028)
1.3.7 Japan Drug Eluting Coronary Stent Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Eluting Coronary Stent Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug Eluting Coronary Stent Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drug Eluting Coronary Stent Demand (2017-2028)
2.2 World Drug Eluting Coronary Stent Consumption by Region
2.2.1 World Drug Eluting Coronary Stent Consumption by Region (2017-2022)
2.2.2 World Drug Eluting Coronary Stent Consumption Forecast by Region (2023-2028)
2.3 United States Drug Eluting Coronary Stent Consumption (2017-2028)
2.4 China Drug Eluting Coronary Stent Consumption (2017-2028)
2.5 Europe Drug Eluting Coronary Stent Consumption (2017-2028)
2.6 Japan Drug Eluting Coronary Stent Consumption (2017-2028)
2.7 South Korea Drug Eluting Coronary Stent Consumption (2017-2028)
2.8 ASEAN Drug Eluting Coronary Stent Consumption (2017-2028)
2.9 India Drug Eluting Coronary Stent Consumption (2017-2028)
3 WORLD DRUG ELUTING CORONARY STENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drug Eluting Coronary Stent Production Value by Manufacturer (2017-2022)
3.2 World Drug Eluting Coronary Stent Production by Manufacturer (2017-2022)
3.3 World Drug Eluting Coronary Stent Average Price by Manufacturer (2017-2022)
3.4 Drug Eluting Coronary Stent Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug Eluting Coronary Stent Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug Eluting Coronary Stent in 2021
3.5.3 Global Concentration Ratios (CR8) for Drug Eluting Coronary Stent in 2021
3.6 Drug Eluting Coronary Stent Market: Overall Company Footprint Analysis
3.6.1 Drug Eluting Coronary Stent Market: Region Footprint
3.6.2 Drug Eluting Coronary Stent Market: Company Product Type Footprint
3.6.3 Drug Eluting Coronary Stent Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drug Eluting Coronary Stent Production Value Comparison
4.1.1 United States VS China: Drug Eluting Coronary Stent Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Drug Eluting Coronary Stent Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Drug Eluting Coronary Stent Production Comparison
4.2.1 United States VS China: Drug Eluting Coronary Stent Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Drug Eluting Coronary Stent Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Drug Eluting Coronary Stent Consumption Comparison
4.3.1 United States VS China: Drug Eluting Coronary Stent Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Drug Eluting Coronary Stent Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Drug Eluting Coronary Stent Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Drug Eluting Coronary Stent in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022)
4.5 China Drug Eluting Coronary Stent Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Drug Eluting Coronary Stent in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Drug Eluting Coronary Stent Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Drug Eluting Coronary Stent in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Eluting Coronary Stent Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Sirolimus
5.2.2 Everolimus
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Drug Eluting Coronary Stent Production by Type (2017-2028)
5.3.2 World Drug Eluting Coronary Stent Production Value by Type (2017-2028)
5.3.3 World Drug Eluting Coronary Stent Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drug Eluting Coronary Stent Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Angina Pectoris
6.2.2 Myocardial Infarction
6.3 Market Segment by Application
6.3.1 World Drug Eluting Coronary Stent Production by Application (2017-2028)
6.3.2 World Drug Eluting Coronary Stent Production Value by Application (2017-2028)
6.3.3 World Drug Eluting Coronary Stent Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Boston Scientific
7.1.1 Boston Scientific Details
7.1.2 Boston Scientific Major Business
7.1.3 Boston Scientific Drug Eluting Coronary Stent Product and Services
7.1.4 Boston Scientific Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Boston Scientific Recent Developments/Updates
7.1.6 Boston Scientific Competitive Strengths & Weaknesses
7.2 Medtronic
7.2.1 Medtronic Details
7.2.2 Medtronic Major Business
7.2.3 Medtronic Drug Eluting Coronary Stent Product and Services
7.2.4 Medtronic Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Medtronic Recent Developments/Updates
7.2.6 Medtronic Competitive Strengths & Weaknesses
7.3 Abbott
7.3.1 Abbott Details
7.3.2 Abbott Major Business
7.3.3 Abbott Drug Eluting Coronary Stent Product and Services
7.3.4 Abbott Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Abbott Recent Developments/Updates
7.3.6 Abbott Competitive Strengths & Weaknesses
7.4 Sahajanand Laser Technology Limited (SLTL Group)
7.4.1 Sahajanand Laser Technology Limited (SLTL Group) Details
7.4.2 Sahajanand Laser Technology Limited (SLTL Group) Major Business
7.4.3 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product and Services
7.4.4 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sahajanand Laser Technology Limited (SLTL Group) Recent Developments/Updates
7.4.6 Sahajanand Laser Technology Limited (SLTL Group) Competitive Strengths & Weaknesses
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Details
7.5.2 Meril Life Sciences Major Business
7.5.3 Meril Life Sciences Drug Eluting Coronary Stent Product and Services
7.5.4 Meril Life Sciences Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Meril Life Sciences Recent Developments/Updates
7.5.6 Meril Life Sciences Competitive Strengths & Weaknesses
7.6 Concept Medical
7.6.1 Concept Medical Details
7.6.2 Concept Medical Major Business
7.6.3 Concept Medical Drug Eluting Coronary Stent Product and Services
7.6.4 Concept Medical Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Concept Medical Recent Developments/Updates
7.6.6 Concept Medical Competitive Strengths & Weaknesses
7.7 BIOTRONIK
7.7.1 BIOTRONIK Details
7.7.2 BIOTRONIK Major Business
7.7.3 BIOTRONIK Drug Eluting Coronary Stent Product and Services
7.7.4 BIOTRONIK Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 BIOTRONIK Recent Developments/Updates
7.7.6 BIOTRONIK Competitive Strengths & Weaknesses
7.8 Relisys
7.8.1 Relisys Details
7.8.2 Relisys Major Business
7.8.3 Relisys Drug Eluting Coronary Stent Product and Services
7.8.4 Relisys Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Relisys Recent Developments/Updates
7.8.6 Relisys Competitive Strengths & Weaknesses
7.9 Lepu Medical Technology(Beijing)
7.9.1 Lepu Medical Technology(Beijing) Details
7.9.2 Lepu Medical Technology(Beijing) Major Business
7.9.3 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product and Services
7.9.4 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Lepu Medical Technology(Beijing) Recent Developments/Updates
7.9.6 Lepu Medical Technology(Beijing) Competitive Strengths & Weaknesses
7.10 Micell Technologies
7.10.1 Micell Technologies Details
7.10.2 Micell Technologies Major Business
7.10.3 Micell Technologies Drug Eluting Coronary Stent Product and Services
7.10.4 Micell Technologies Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Micell Technologies Recent Developments/Updates
7.10.6 Micell Technologies Competitive Strengths & Weaknesses
7.11 Terumo Corporation
7.11.1 Terumo Corporation Details
7.11.2 Terumo Corporation Major Business
7.11.3 Terumo Corporation Drug Eluting Coronary Stent Product and Services
7.11.4 Terumo Corporation Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Terumo Corporation Recent Developments/Updates
7.11.6 Terumo Corporation Competitive Strengths & Weaknesses
7.12 Biosensors International
7.12.1 Biosensors International Details
7.12.2 Biosensors International Major Business
7.12.3 Biosensors International Drug Eluting Coronary Stent Product and Services
7.12.4 Biosensors International Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Biosensors International Recent Developments/Updates
7.12.6 Biosensors International Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Drug Eluting Coronary Stent and Key Manufacturers
8.2 Drug Eluting Coronary Stent Manufacturing Costs
8.3 Drug Eluting Coronary Stent Production Process
8.4 Drug Eluting Coronary Stent Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Drug Eluting Coronary Stent Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Drug Eluting Coronary Stent Typical Distributors
9.3 Drug Eluting Coronary Stent Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Drug Eluting Coronary Stent Introduction
1.2 World Drug Eluting Coronary Stent Supply & Forecast
1.2.1 World Drug Eluting Coronary Stent Production Value (2017 & 2021 & 2028)
1.2.2 World Drug Eluting Coronary Stent Production (2017-2028)
1.2.3 World Drug Eluting Coronary Stent Pricing Trends (2017-2028)
1.3 World Drug Eluting Coronary Stent Production by Region
1.3.1 World Drug Eluting Coronary Stent Production Value by Region (2017-2028)
1.3.2 World Drug Eluting Coronary Stent Production by Region (2017-2028)
1.3.3 World Drug Eluting Coronary Stent Average Price by Region (2017-2028)
1.3.4 North America Drug Eluting Coronary Stent Production (2017-2028)
1.3.5 Europe Drug Eluting Coronary Stent Production (2017-2028)
1.3.6 China Drug Eluting Coronary Stent Production (2017-2028)
1.3.7 Japan Drug Eluting Coronary Stent Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Eluting Coronary Stent Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug Eluting Coronary Stent Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drug Eluting Coronary Stent Demand (2017-2028)
2.2 World Drug Eluting Coronary Stent Consumption by Region
2.2.1 World Drug Eluting Coronary Stent Consumption by Region (2017-2022)
2.2.2 World Drug Eluting Coronary Stent Consumption Forecast by Region (2023-2028)
2.3 United States Drug Eluting Coronary Stent Consumption (2017-2028)
2.4 China Drug Eluting Coronary Stent Consumption (2017-2028)
2.5 Europe Drug Eluting Coronary Stent Consumption (2017-2028)
2.6 Japan Drug Eluting Coronary Stent Consumption (2017-2028)
2.7 South Korea Drug Eluting Coronary Stent Consumption (2017-2028)
2.8 ASEAN Drug Eluting Coronary Stent Consumption (2017-2028)
2.9 India Drug Eluting Coronary Stent Consumption (2017-2028)
3 WORLD DRUG ELUTING CORONARY STENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drug Eluting Coronary Stent Production Value by Manufacturer (2017-2022)
3.2 World Drug Eluting Coronary Stent Production by Manufacturer (2017-2022)
3.3 World Drug Eluting Coronary Stent Average Price by Manufacturer (2017-2022)
3.4 Drug Eluting Coronary Stent Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug Eluting Coronary Stent Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug Eluting Coronary Stent in 2021
3.5.3 Global Concentration Ratios (CR8) for Drug Eluting Coronary Stent in 2021
3.6 Drug Eluting Coronary Stent Market: Overall Company Footprint Analysis
3.6.1 Drug Eluting Coronary Stent Market: Region Footprint
3.6.2 Drug Eluting Coronary Stent Market: Company Product Type Footprint
3.6.3 Drug Eluting Coronary Stent Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drug Eluting Coronary Stent Production Value Comparison
4.1.1 United States VS China: Drug Eluting Coronary Stent Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Drug Eluting Coronary Stent Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Drug Eluting Coronary Stent Production Comparison
4.2.1 United States VS China: Drug Eluting Coronary Stent Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Drug Eluting Coronary Stent Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Drug Eluting Coronary Stent Consumption Comparison
4.3.1 United States VS China: Drug Eluting Coronary Stent Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Drug Eluting Coronary Stent Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Drug Eluting Coronary Stent Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Drug Eluting Coronary Stent in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022)
4.5 China Drug Eluting Coronary Stent Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Drug Eluting Coronary Stent in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Drug Eluting Coronary Stent Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Drug Eluting Coronary Stent in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Eluting Coronary Stent Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Sirolimus
5.2.2 Everolimus
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Drug Eluting Coronary Stent Production by Type (2017-2028)
5.3.2 World Drug Eluting Coronary Stent Production Value by Type (2017-2028)
5.3.3 World Drug Eluting Coronary Stent Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drug Eluting Coronary Stent Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Angina Pectoris
6.2.2 Myocardial Infarction
6.3 Market Segment by Application
6.3.1 World Drug Eluting Coronary Stent Production by Application (2017-2028)
6.3.2 World Drug Eluting Coronary Stent Production Value by Application (2017-2028)
6.3.3 World Drug Eluting Coronary Stent Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Boston Scientific
7.1.1 Boston Scientific Details
7.1.2 Boston Scientific Major Business
7.1.3 Boston Scientific Drug Eluting Coronary Stent Product and Services
7.1.4 Boston Scientific Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Boston Scientific Recent Developments/Updates
7.1.6 Boston Scientific Competitive Strengths & Weaknesses
7.2 Medtronic
7.2.1 Medtronic Details
7.2.2 Medtronic Major Business
7.2.3 Medtronic Drug Eluting Coronary Stent Product and Services
7.2.4 Medtronic Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Medtronic Recent Developments/Updates
7.2.6 Medtronic Competitive Strengths & Weaknesses
7.3 Abbott
7.3.1 Abbott Details
7.3.2 Abbott Major Business
7.3.3 Abbott Drug Eluting Coronary Stent Product and Services
7.3.4 Abbott Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Abbott Recent Developments/Updates
7.3.6 Abbott Competitive Strengths & Weaknesses
7.4 Sahajanand Laser Technology Limited (SLTL Group)
7.4.1 Sahajanand Laser Technology Limited (SLTL Group) Details
7.4.2 Sahajanand Laser Technology Limited (SLTL Group) Major Business
7.4.3 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product and Services
7.4.4 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Sahajanand Laser Technology Limited (SLTL Group) Recent Developments/Updates
7.4.6 Sahajanand Laser Technology Limited (SLTL Group) Competitive Strengths & Weaknesses
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Details
7.5.2 Meril Life Sciences Major Business
7.5.3 Meril Life Sciences Drug Eluting Coronary Stent Product and Services
7.5.4 Meril Life Sciences Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Meril Life Sciences Recent Developments/Updates
7.5.6 Meril Life Sciences Competitive Strengths & Weaknesses
7.6 Concept Medical
7.6.1 Concept Medical Details
7.6.2 Concept Medical Major Business
7.6.3 Concept Medical Drug Eluting Coronary Stent Product and Services
7.6.4 Concept Medical Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Concept Medical Recent Developments/Updates
7.6.6 Concept Medical Competitive Strengths & Weaknesses
7.7 BIOTRONIK
7.7.1 BIOTRONIK Details
7.7.2 BIOTRONIK Major Business
7.7.3 BIOTRONIK Drug Eluting Coronary Stent Product and Services
7.7.4 BIOTRONIK Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 BIOTRONIK Recent Developments/Updates
7.7.6 BIOTRONIK Competitive Strengths & Weaknesses
7.8 Relisys
7.8.1 Relisys Details
7.8.2 Relisys Major Business
7.8.3 Relisys Drug Eluting Coronary Stent Product and Services
7.8.4 Relisys Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Relisys Recent Developments/Updates
7.8.6 Relisys Competitive Strengths & Weaknesses
7.9 Lepu Medical Technology(Beijing)
7.9.1 Lepu Medical Technology(Beijing) Details
7.9.2 Lepu Medical Technology(Beijing) Major Business
7.9.3 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product and Services
7.9.4 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Lepu Medical Technology(Beijing) Recent Developments/Updates
7.9.6 Lepu Medical Technology(Beijing) Competitive Strengths & Weaknesses
7.10 Micell Technologies
7.10.1 Micell Technologies Details
7.10.2 Micell Technologies Major Business
7.10.3 Micell Technologies Drug Eluting Coronary Stent Product and Services
7.10.4 Micell Technologies Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Micell Technologies Recent Developments/Updates
7.10.6 Micell Technologies Competitive Strengths & Weaknesses
7.11 Terumo Corporation
7.11.1 Terumo Corporation Details
7.11.2 Terumo Corporation Major Business
7.11.3 Terumo Corporation Drug Eluting Coronary Stent Product and Services
7.11.4 Terumo Corporation Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Terumo Corporation Recent Developments/Updates
7.11.6 Terumo Corporation Competitive Strengths & Weaknesses
7.12 Biosensors International
7.12.1 Biosensors International Details
7.12.2 Biosensors International Major Business
7.12.3 Biosensors International Drug Eluting Coronary Stent Product and Services
7.12.4 Biosensors International Drug Eluting Coronary Stent Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Biosensors International Recent Developments/Updates
7.12.6 Biosensors International Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Drug Eluting Coronary Stent and Key Manufacturers
8.2 Drug Eluting Coronary Stent Manufacturing Costs
8.3 Drug Eluting Coronary Stent Production Process
8.4 Drug Eluting Coronary Stent Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Drug Eluting Coronary Stent Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Drug Eluting Coronary Stent Typical Distributors
9.3 Drug Eluting Coronary Stent Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Drug Eluting Coronary Stent Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Drug Eluting Coronary Stent Production Value by Region (2017-2022) & (USD Million)
Table 3. World Drug Eluting Coronary Stent Production Value by Region (2023-2028) & (USD Million)
Table 4. World Drug Eluting Coronary Stent Production Value Market Share by Region (2017-2022)
Table 5. World Drug Eluting Coronary Stent Production Value Market Share by Region (2023-2028)
Table 6. World Drug Eluting Coronary Stent Production by Region (2017-2022) & (K Units)
Table 7. World Drug Eluting Coronary Stent Production by Region (2023-2028) & (K Units)
Table 8. World Drug Eluting Coronary Stent Production Market Share by Region (2017-2022)
Table 9. World Drug Eluting Coronary Stent Production Market Share by Region (2023-2028)
Table 10. World Drug Eluting Coronary Stent Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Drug Eluting Coronary Stent Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Drug Eluting Coronary Stent Major Market Trends
Table 13. World Drug Eluting Coronary Stent Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Drug Eluting Coronary Stent Consumption by Region (2017-2022) & (K Units)
Table 15. World Drug Eluting Coronary Stent Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Drug Eluting Coronary Stent Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Drug Eluting Coronary Stent Producers in 2021
Table 18. World Drug Eluting Coronary Stent Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Drug Eluting Coronary Stent Producers in 2021
Table 20. World Drug Eluting Coronary Stent Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Drug Eluting Coronary Stent Company Evaluation Quadrant
Table 22. World Drug Eluting Coronary Stent Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Drug Eluting Coronary Stent Production Site of Key Manufacturer
Table 24. Drug Eluting Coronary Stent Market: Company Product Type Footprint
Table 25. Drug Eluting Coronary Stent Market: Company Product Application Footprint
Table 26. Drug Eluting Coronary Stent Competitive Factors
Table 27. Drug Eluting Coronary Stent New Entrant and Capacity Expansion Plans
Table 28. Drug Eluting Coronary Stent Mergers & Acquisitions Activity
Table 29. United States VS China Drug Eluting Coronary Stent Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Drug Eluting Coronary Stent Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Drug Eluting Coronary Stent Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Drug Eluting Coronary Stent in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Drug Eluting Coronary Stent Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Drug Eluting Coronary Stent Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Drug Eluting Coronary Stent in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Drug Eluting Coronary Stent Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Drug Eluting Coronary Stent Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Drug Eluting Coronary Stent in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Drug Eluting Coronary Stent Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Drug Eluting Coronary Stent Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Drug Eluting Coronary Stent Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Drug Eluting Coronary Stent Production by Type (2017-2022) & (K Units)
Table 49. World Drug Eluting Coronary Stent Production by Type (2023-2028) & (K Units)
Table 50. World Drug Eluting Coronary Stent Production Value by Type (2017-2022) & (USD Million)
Table 51. World Drug Eluting Coronary Stent Production Value by Type (2023-2028) & (USD Million)
Table 52. World Drug Eluting Coronary Stent Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Drug Eluting Coronary Stent Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Drug Eluting Coronary Stent Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Drug Eluting Coronary Stent Production by Application (2017-2022) & (K Units)
Table 56. World Drug Eluting Coronary Stent Production by Application (2023-2028) & (K Units)
Table 57. World Drug Eluting Coronary Stent Production Value by Application (2017-2022) & (USD Million)
Table 58. World Drug Eluting Coronary Stent Production Value by Application (2023-2028) & (USD Million)
Table 59. World Drug Eluting Coronary Stent Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Drug Eluting Coronary Stent Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 62. Boston Scientific Major Business
Table 63. Boston Scientific Drug Eluting Coronary Stent Product and Services
Table 64. Boston Scientific Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Boston Scientific Recent Developments/Updates
Table 66. Boston Scientific Competitive Strengths & Weaknesses
Table 67. Medtronic Basic Information, Manufacturing Base and Competitors
Table 68. Medtronic Major Business
Table 69. Medtronic Drug Eluting Coronary Stent Product and Services
Table 70. Medtronic Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Medtronic Recent Developments/Updates
Table 72. Medtronic Competitive Strengths & Weaknesses
Table 73. Abbott Basic Information, Manufacturing Base and Competitors
Table 74. Abbott Major Business
Table 75. Abbott Drug Eluting Coronary Stent Product and Services
Table 76. Abbott Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Abbott Recent Developments/Updates
Table 78. Abbott Competitive Strengths & Weaknesses
Table 79. Sahajanand Laser Technology Limited (SLTL Group) Basic Information, Manufacturing Base and Competitors
Table 80. Sahajanand Laser Technology Limited (SLTL Group) Major Business
Table 81. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product and Services
Table 82. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sahajanand Laser Technology Limited (SLTL Group) Recent Developments/Updates
Table 84. Sahajanand Laser Technology Limited (SLTL Group) Competitive Strengths & Weaknesses
Table 85. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 86. Meril Life Sciences Major Business
Table 87. Meril Life Sciences Drug Eluting Coronary Stent Product and Services
Table 88. Meril Life Sciences Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Meril Life Sciences Recent Developments/Updates
Table 90. Meril Life Sciences Competitive Strengths & Weaknesses
Table 91. Concept Medical Basic Information, Manufacturing Base and Competitors
Table 92. Concept Medical Major Business
Table 93. Concept Medical Drug Eluting Coronary Stent Product and Services
Table 94. Concept Medical Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Concept Medical Recent Developments/Updates
Table 96. Concept Medical Competitive Strengths & Weaknesses
Table 97. BIOTRONIK Basic Information, Manufacturing Base and Competitors
Table 98. BIOTRONIK Major Business
Table 99. BIOTRONIK Drug Eluting Coronary Stent Product and Services
Table 100. BIOTRONIK Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. BIOTRONIK Recent Developments/Updates
Table 102. BIOTRONIK Competitive Strengths & Weaknesses
Table 103. Relisys Basic Information, Manufacturing Base and Competitors
Table 104. Relisys Major Business
Table 105. Relisys Drug Eluting Coronary Stent Product and Services
Table 106. Relisys Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Relisys Recent Developments/Updates
Table 108. Relisys Competitive Strengths & Weaknesses
Table 109. Lepu Medical Technology(Beijing) Basic Information, Manufacturing Base and Competitors
Table 110. Lepu Medical Technology(Beijing) Major Business
Table 111. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product and Services
Table 112. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Lepu Medical Technology(Beijing) Recent Developments/Updates
Table 114. Lepu Medical Technology(Beijing) Competitive Strengths & Weaknesses
Table 115. Micell Technologies Basic Information, Manufacturing Base and Competitors
Table 116. Micell Technologies Major Business
Table 117. Micell Technologies Drug Eluting Coronary Stent Product and Services
Table 118. Micell Technologies Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Micell Technologies Recent Developments/Updates
Table 120. Micell Technologies Competitive Strengths & Weaknesses
Table 121. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 122. Terumo Corporation Major Business
Table 123. Terumo Corporation Drug Eluting Coronary Stent Product and Services
Table 124. Terumo Corporation Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Terumo Corporation Recent Developments/Updates
Table 126. Biosensors International Basic Information, Manufacturing Base and Competitors
Table 127. Biosensors International Major Business
Table 128. Biosensors International Drug Eluting Coronary Stent Product and Services
Table 129. Biosensors International Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Drug Eluting Coronary Stent Raw Material
Table 131. Key Manufacturers of Drug Eluting Coronary Stent Raw Materials
Table 132. Drug Eluting Coronary Stent Typical Distributors
Table 133. Drug Eluting Coronary Stent Typical Customers
Table 1. World Drug Eluting Coronary Stent Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Drug Eluting Coronary Stent Production Value by Region (2017-2022) & (USD Million)
Table 3. World Drug Eluting Coronary Stent Production Value by Region (2023-2028) & (USD Million)
Table 4. World Drug Eluting Coronary Stent Production Value Market Share by Region (2017-2022)
Table 5. World Drug Eluting Coronary Stent Production Value Market Share by Region (2023-2028)
Table 6. World Drug Eluting Coronary Stent Production by Region (2017-2022) & (K Units)
Table 7. World Drug Eluting Coronary Stent Production by Region (2023-2028) & (K Units)
Table 8. World Drug Eluting Coronary Stent Production Market Share by Region (2017-2022)
Table 9. World Drug Eluting Coronary Stent Production Market Share by Region (2023-2028)
Table 10. World Drug Eluting Coronary Stent Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Drug Eluting Coronary Stent Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Drug Eluting Coronary Stent Major Market Trends
Table 13. World Drug Eluting Coronary Stent Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Drug Eluting Coronary Stent Consumption by Region (2017-2022) & (K Units)
Table 15. World Drug Eluting Coronary Stent Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Drug Eluting Coronary Stent Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Drug Eluting Coronary Stent Producers in 2021
Table 18. World Drug Eluting Coronary Stent Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Drug Eluting Coronary Stent Producers in 2021
Table 20. World Drug Eluting Coronary Stent Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Drug Eluting Coronary Stent Company Evaluation Quadrant
Table 22. World Drug Eluting Coronary Stent Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Drug Eluting Coronary Stent Production Site of Key Manufacturer
Table 24. Drug Eluting Coronary Stent Market: Company Product Type Footprint
Table 25. Drug Eluting Coronary Stent Market: Company Product Application Footprint
Table 26. Drug Eluting Coronary Stent Competitive Factors
Table 27. Drug Eluting Coronary Stent New Entrant and Capacity Expansion Plans
Table 28. Drug Eluting Coronary Stent Mergers & Acquisitions Activity
Table 29. United States VS China Drug Eluting Coronary Stent Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Drug Eluting Coronary Stent Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Drug Eluting Coronary Stent Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Drug Eluting Coronary Stent in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Drug Eluting Coronary Stent Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Drug Eluting Coronary Stent Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Drug Eluting Coronary Stent in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Drug Eluting Coronary Stent Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Drug Eluting Coronary Stent Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Drug Eluting Coronary Stent in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Drug Eluting Coronary Stent Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Drug Eluting Coronary Stent Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Drug Eluting Coronary Stent Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Drug Eluting Coronary Stent Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Drug Eluting Coronary Stent Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Drug Eluting Coronary Stent Production by Type (2017-2022) & (K Units)
Table 49. World Drug Eluting Coronary Stent Production by Type (2023-2028) & (K Units)
Table 50. World Drug Eluting Coronary Stent Production Value by Type (2017-2022) & (USD Million)
Table 51. World Drug Eluting Coronary Stent Production Value by Type (2023-2028) & (USD Million)
Table 52. World Drug Eluting Coronary Stent Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Drug Eluting Coronary Stent Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Drug Eluting Coronary Stent Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Drug Eluting Coronary Stent Production by Application (2017-2022) & (K Units)
Table 56. World Drug Eluting Coronary Stent Production by Application (2023-2028) & (K Units)
Table 57. World Drug Eluting Coronary Stent Production Value by Application (2017-2022) & (USD Million)
Table 58. World Drug Eluting Coronary Stent Production Value by Application (2023-2028) & (USD Million)
Table 59. World Drug Eluting Coronary Stent Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Drug Eluting Coronary Stent Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 62. Boston Scientific Major Business
Table 63. Boston Scientific Drug Eluting Coronary Stent Product and Services
Table 64. Boston Scientific Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Boston Scientific Recent Developments/Updates
Table 66. Boston Scientific Competitive Strengths & Weaknesses
Table 67. Medtronic Basic Information, Manufacturing Base and Competitors
Table 68. Medtronic Major Business
Table 69. Medtronic Drug Eluting Coronary Stent Product and Services
Table 70. Medtronic Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Medtronic Recent Developments/Updates
Table 72. Medtronic Competitive Strengths & Weaknesses
Table 73. Abbott Basic Information, Manufacturing Base and Competitors
Table 74. Abbott Major Business
Table 75. Abbott Drug Eluting Coronary Stent Product and Services
Table 76. Abbott Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Abbott Recent Developments/Updates
Table 78. Abbott Competitive Strengths & Weaknesses
Table 79. Sahajanand Laser Technology Limited (SLTL Group) Basic Information, Manufacturing Base and Competitors
Table 80. Sahajanand Laser Technology Limited (SLTL Group) Major Business
Table 81. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product and Services
Table 82. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Sahajanand Laser Technology Limited (SLTL Group) Recent Developments/Updates
Table 84. Sahajanand Laser Technology Limited (SLTL Group) Competitive Strengths & Weaknesses
Table 85. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 86. Meril Life Sciences Major Business
Table 87. Meril Life Sciences Drug Eluting Coronary Stent Product and Services
Table 88. Meril Life Sciences Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Meril Life Sciences Recent Developments/Updates
Table 90. Meril Life Sciences Competitive Strengths & Weaknesses
Table 91. Concept Medical Basic Information, Manufacturing Base and Competitors
Table 92. Concept Medical Major Business
Table 93. Concept Medical Drug Eluting Coronary Stent Product and Services
Table 94. Concept Medical Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Concept Medical Recent Developments/Updates
Table 96. Concept Medical Competitive Strengths & Weaknesses
Table 97. BIOTRONIK Basic Information, Manufacturing Base and Competitors
Table 98. BIOTRONIK Major Business
Table 99. BIOTRONIK Drug Eluting Coronary Stent Product and Services
Table 100. BIOTRONIK Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. BIOTRONIK Recent Developments/Updates
Table 102. BIOTRONIK Competitive Strengths & Weaknesses
Table 103. Relisys Basic Information, Manufacturing Base and Competitors
Table 104. Relisys Major Business
Table 105. Relisys Drug Eluting Coronary Stent Product and Services
Table 106. Relisys Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Relisys Recent Developments/Updates
Table 108. Relisys Competitive Strengths & Weaknesses
Table 109. Lepu Medical Technology(Beijing) Basic Information, Manufacturing Base and Competitors
Table 110. Lepu Medical Technology(Beijing) Major Business
Table 111. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product and Services
Table 112. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Lepu Medical Technology(Beijing) Recent Developments/Updates
Table 114. Lepu Medical Technology(Beijing) Competitive Strengths & Weaknesses
Table 115. Micell Technologies Basic Information, Manufacturing Base and Competitors
Table 116. Micell Technologies Major Business
Table 117. Micell Technologies Drug Eluting Coronary Stent Product and Services
Table 118. Micell Technologies Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Micell Technologies Recent Developments/Updates
Table 120. Micell Technologies Competitive Strengths & Weaknesses
Table 121. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 122. Terumo Corporation Major Business
Table 123. Terumo Corporation Drug Eluting Coronary Stent Product and Services
Table 124. Terumo Corporation Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Terumo Corporation Recent Developments/Updates
Table 126. Biosensors International Basic Information, Manufacturing Base and Competitors
Table 127. Biosensors International Major Business
Table 128. Biosensors International Drug Eluting Coronary Stent Product and Services
Table 129. Biosensors International Drug Eluting Coronary Stent Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Drug Eluting Coronary Stent Raw Material
Table 131. Key Manufacturers of Drug Eluting Coronary Stent Raw Materials
Table 132. Drug Eluting Coronary Stent Typical Distributors
Table 133. Drug Eluting Coronary Stent Typical Customers
LIST OF FIGURES
Figure 1. Drug Eluting Coronary Stent Picture
Figure 2. World Drug Eluting Coronary Stent Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Drug Eluting Coronary Stent Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 5. World Drug Eluting Coronary Stent Average Price (2017-2028) & (US$/Unit)
Figure 6. World Drug Eluting Coronary Stent Production Value Market Share by Region (2017-2028)
Figure 7. World Drug Eluting Coronary Stent Production Market Share by Region (2017-2028)
Figure 8. North America Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 9. Europe Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 10. China Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 11. Japan Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 12. Drug Eluting Coronary Stent Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drug Eluting Coronary Stent Demand (2017-2028) & (K Units)
Figure 15. World Drug Eluting Coronary Stent Consumption Market Share by Region (2017-2028)
Figure 16. United States Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 17. China Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 18. Europe Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 19. Japan Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 20. South Korea Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 22. India Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Drug Eluting Coronary Stent by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drug Eluting Coronary Stent Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drug Eluting Coronary Stent Markets in 2021
Figure 26. United States VS China: Drug Eluting Coronary Stent Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Drug Eluting Coronary Stent Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Drug Eluting Coronary Stent Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Drug Eluting Coronary Stent in United States
Figure 30. Key Producers and Market Share of Drug Eluting Coronary Stent in China
Figure 31. Key Producers and Market Share of Drug Eluting Coronary Stent in Rest of World
Figure 32. World Drug Eluting Coronary Stent Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Drug Eluting Coronary Stent Production Value Market Share by Type in 2021
Figure 34. Sirolimus
Figure 35. Everolimus
Figure 36. Others
Figure 37. World Drug Eluting Coronary Stent Production Market Share by Type (2017-2028)
Figure 38. World Drug Eluting Coronary Stent Production Value Market Share by Type (2017-2028)
Figure 39. World Drug Eluting Coronary Stent Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Drug Eluting Coronary Stent Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Drug Eluting Coronary Stent Production Value Market Share by Application in 2021
Figure 42. Angina Pectoris
Figure 43. Myocardial Infarction
Figure 44. World Drug Eluting Coronary Stent Production Market Share by Application (2017-2028)
Figure 45. World Drug Eluting Coronary Stent Production Value Market Share by Application (2017-2028)
Figure 46. World Drug Eluting Coronary Stent Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Drug Eluting Coronary Stent in 2021
Figure 48. Manufacturing Process Analysis of Drug Eluting Coronary Stent
Figure 49. Drug Eluting Coronary Stent Industrial Chain
Figure 50. Distribution Channel Breakdown for Drug Eluting Coronary Stent Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Drug Eluting Coronary Stent Picture
Figure 2. World Drug Eluting Coronary Stent Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Drug Eluting Coronary Stent Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 5. World Drug Eluting Coronary Stent Average Price (2017-2028) & (US$/Unit)
Figure 6. World Drug Eluting Coronary Stent Production Value Market Share by Region (2017-2028)
Figure 7. World Drug Eluting Coronary Stent Production Market Share by Region (2017-2028)
Figure 8. North America Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 9. Europe Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 10. China Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 11. Japan Drug Eluting Coronary Stent Production (2017-2028) & (K Units)
Figure 12. Drug Eluting Coronary Stent Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drug Eluting Coronary Stent Demand (2017-2028) & (K Units)
Figure 15. World Drug Eluting Coronary Stent Consumption Market Share by Region (2017-2028)
Figure 16. United States Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 17. China Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 18. Europe Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 19. Japan Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 20. South Korea Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 22. India Drug Eluting Coronary Stent Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Drug Eluting Coronary Stent by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drug Eluting Coronary Stent Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drug Eluting Coronary Stent Markets in 2021
Figure 26. United States VS China: Drug Eluting Coronary Stent Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Drug Eluting Coronary Stent Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Drug Eluting Coronary Stent Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Drug Eluting Coronary Stent in United States
Figure 30. Key Producers and Market Share of Drug Eluting Coronary Stent in China
Figure 31. Key Producers and Market Share of Drug Eluting Coronary Stent in Rest of World
Figure 32. World Drug Eluting Coronary Stent Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Drug Eluting Coronary Stent Production Value Market Share by Type in 2021
Figure 34. Sirolimus
Figure 35. Everolimus
Figure 36. Others
Figure 37. World Drug Eluting Coronary Stent Production Market Share by Type (2017-2028)
Figure 38. World Drug Eluting Coronary Stent Production Value Market Share by Type (2017-2028)
Figure 39. World Drug Eluting Coronary Stent Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Drug Eluting Coronary Stent Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Drug Eluting Coronary Stent Production Value Market Share by Application in 2021
Figure 42. Angina Pectoris
Figure 43. Myocardial Infarction
Figure 44. World Drug Eluting Coronary Stent Production Market Share by Application (2017-2028)
Figure 45. World Drug Eluting Coronary Stent Production Value Market Share by Application (2017-2028)
Figure 46. World Drug Eluting Coronary Stent Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Drug Eluting Coronary Stent in 2021
Figure 48. Manufacturing Process Analysis of Drug Eluting Coronary Stent
Figure 49. Drug Eluting Coronary Stent Industrial Chain
Figure 50. Distribution Channel Breakdown for Drug Eluting Coronary Stent Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
